Matthew Pauls
CIK 1573429 · CHIEF EXECUTIVE OFFICER · last filed 2026-05-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$6.68M
Companies
6
Total Filings
44
Lifetime Open-Market Net
-$777.7K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SLNO | Director | 0 | $53.01 | $0 | -$424.8K | 5 | 2026-05-18 |
| PTHS | Director | 15,521 | $27.50 | $426.8K | -$16.4K | 4 | 2026-04-06 |
| SVRA | CHIEF EXECUTIVE OFFICER | 1,188,050 | $5.26 | $6.25M | -$336.5K | 21 | 2025-12-16 |
| Strongbridge Biopharma plc (SBBP) Delisted | President & CEO | 72,608 | $2.00 | $145.2K | $0 | 3 | 2019-02-22 |
| MSTX | Director | — | $16.18 | — | $0 | 3 | 2017-01-23 |
| INSM | Chief Commercial Officer | — | $97.85 | — | $0 | 3 | 2014-01-14 |
Recent Filings · Page 5 of 5
44 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-11-02 | MSTX | Grant (A) | — | $0 | EDGAR |
| 2014-01-14 | INSM | Grant (A) | — | $0 | EDGAR |
| 2013-05-28 | INSM | Grant (A) | — | $0 | EDGAR |
| 2013-04-03 | INSM | Grant (A) | — | $0 | EDGAR |
Showing 41–44 of 44
Prev
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.